GENESIS HEALTHCARE INC's next confirmed earnings release is scheduled for November 9, 2026.
| Earnings Date | 11/9/2026 |
As of December 31, 2020, GENESIS HEALTHCARE INC has 111.55M shares outstanding.
| Shares Outstanding | 111.55M |
As of December 31, 2020, GENESIS HEALTHCARE INC maintains a current ratio of 0.23, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -327.83, indicating conservative leverage, while an interest coverage ratio of -1.34 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.23 |
| Quick Ratio | 0.17 |
| Debt / Equity | -327.83 |
| Debt / EBITDA | -20.94 |
| Interest Coverage | -1.34 |
These figures cover the twelve months ended December 31, 2020. Return on assets (ROA) is negative at -1.35, reflecting losses generated across the asset base. The company generates approximately 73,702.32 in revenue per employee across its workforce of 53,000.00, a quick read on workforce productivity versus industry peers.
| Return on Assets (ROA) | -1.35 |
| Revenue Per Employee | 73,702.32 |
| Employee Count | 53,000.00 |
Over the twelve months ended December 31, 2020, GENESIS HEALTHCARE INC recorded an income tax benefit of -3.61M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -106.98M and -58.96M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -3.61M |
Over the twelve months ended December 31, 2020, GENESIS HEALTHCARE INC generated 3.91B in revenue and converted that into -58.96M in net income, yielding earnings per share of -0.82. EBITDA reached -181.93M, while operating income came in at -269.78M.
| Revenue | 3.91B |
| Gross Profit | 1.65B |
| Operating Income | -269.78M |
| Pretax Income | -106.98M |
| Net Income | -58.96M |
| EBITDA | -181.93M |
| EBIT | -289.76M |
| Earnings Per Share (EPS) | -0.82 |
As of December 31, 2020, GENESIS HEALTHCARE INC holds 212.07M in cash and equivalents against 3.81B in total debt, resulting in a net debt position of 1.33B. Total book value stands at -820.22M, with working capital of -2.98B providing operational flexibility.
| Cash & Cash Equivalents | 212.07M |
| Total Debt | 3.81B |
| Net Debt | 1.33B |
| Equity (Book Value) | -820.22M |
| Book Value Per Share | -7.35 |
| Working Capital | -2.98B |
GENESIS HEALTHCARE INC produced 315.73M in operating cash flow over the twelve months ended December 31, 2020.
| Operating Cash Flow | 315.73M |
| Free Cash Flow | 315.73M |
| FCF Per Share | 2.83 |
Over the twelve months ended December 31, 2020, GENESIS HEALTHCARE INC posted a gross margin of 42.24, reflecting its pricing power and cost economics. The operating margin of -6.91 and net profit margin of -1.51 provide insight into operational efficiency.
| Gross Margin | 42.24 |
| Operating Margin | -6.91 |
| Pretax Margin | -2.74 |
| Profit Margin | -1.51 |
| EBITDA Margin | -4.66 |